We treated 64 patients with the diagnosis of laryngitis gastrica with Antra
(Omeprazol) in doses of 10, 20, and 40 mg. To determine the success of the
therapy, pH monitoring of the esophagus and hypopharynx, the voice status
and measurement of vocal penetrating capacity were used. The results prove
that a 20-mg dose of Antra is suitable for the therapy of laryngitis gastri
ca with a high rate of success. Problems which arose during the investigati
on, consequent changes of the original concept of the project as well as ne
w aspects and questions which resulted from this are discussed with respect
to further investigation.